Company Search:
Advanced Search
Sponsored Links
Mesoblast Ltd - ADR Company Snapshot
Mesoblast Ltd - ADR operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd - ADR with three other miscellaneous service companies in North America: Applied Genetic Technologies Corp (2016 sales of $47.36 million ), Pharmaxis Ltd ($13.50 million of which 80% was Bronchitol and Aridol), and Neptune Technologies & Bioressources Inc which is based in Canada (22.63 million Canadian Dollars [US$17.26 million] ).

Sales Analysis. During the year ended June of 2016, sales at Mesoblast Ltd - ADR were $42.55 million. This is an increase of 116.5% versus 2015, when the company's sales were $19.65 million.
  Stock Performance Chart for Mesoblast Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 4.32
(Figures in U.S. Dollars)
1 Week -2.7%   13 Weeks -3.4%  
4 Weeks 4.9%   52 Weeks -66.0%  
Mesoblast Ltd - ADR Key Data:
  Ticker: MESO Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 42,547,862
(Year Ending Jan 2017).
Employees: 108
  Currency: U.S. Dollars Market Cap: 326,482,390
  Fiscal Yr Ends: June Shares Outstanding: 75,574,627
  Share Type: Ordinary Closely Held Shares: 34,429,495
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.